Did Thomas Carper buy Revance Therapeutics stock?

Common questions

Did Thomas Carper buy Revance Therapeutics stock?

Yes. Thomas Carper disclosed 1 purchase of Revance Therapeutics (RVNC) stock on Oct 4, 2023, in STOCK Act reports. Added together, the disclosed ranges come to $1K-$15K.

How big were Thomas Carper's Revance Therapeutics trades?

STOCK Act reports give a range for each trade, such as $1K-$15K, never an exact amount. Added together, the disclosed ranges come to $1K-$15K.

Did Thomas Carper make these Revance Therapeutics trades personally?

Not always. The STOCK Act requires members to report trades by themselves, a spouse and dependent children. The owner column of each linked filing says whose trade it was.

Does Thomas Carper still own Revance Therapeutics stock?

This page lists reported trades, not holdings. A purchase can have been sold since, and the filings shown do not say what is held today.

When did Thomas Carper report these trades?

The latest filing is dated Nov 2, 2023. The STOCK Act gives members of Congress 45 days to report a trade, so a filing can trail the trade by weeks. Every row shows both dates.

Where does this data come from?

From periodic transaction reports filed under the STOCK Act with the Secretary of the Senate. Every trade links to the original filing.